NBY — NovaBay Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for NovaBay Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.5	5.36	3.13	0.43	7.96
Net Total Accounts Receivable
Net Total Receivables	1.67	1.97	0.759	0.389	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13.2	11.3	7.15	1.94	8.68
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.604	1.95	1.38	1.01	0
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	24	16.4	9.03	3.42	9.04
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.44	4.26	4.28	2.84	1.14
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.8	5.84	5.72	3.55	31.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	10.2	10.6	3.31	-0.129	-22.8
Total Liabilities & Shareholders' Equity	24	16.4	9.03	3.42	9.04
Total Common Shares Outstanding
Total Preferred Shares Outstanding